RadNet Inc
NASDAQ:RDNT

Watchlist Manager
RadNet Inc Logo
RadNet Inc
NASDAQ:RDNT
Watchlist
Price: 61.28 USD 1.98%
Market Cap: $4.8B

RadNet Inc
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

RadNet Inc
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
RadNet Inc
NASDAQ:RDNT
Total Equity
$1.1B
CAGR 3-Years
48%
CAGR 5-Years
46%
CAGR 10-Years
42%
Quest Diagnostics Inc
NYSE:DGX
Total Equity
$7.2B
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
4%
CVS Health Corp
NYSE:CVS
Total Equity
$75.2B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
7%
Cigna Corp
NYSE:CI
Total Equity
$41.7B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
13%
Laboratory Corporation of America Holdings
NYSE:LH
Total Equity
$8.6B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
6%
Guardant Health Inc
NASDAQ:GH
Total Equity
-$99.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

RadNet Inc
Glance View

RadNet Inc. stands as a formidable entity in the realm of diagnostic imaging services, charting its course as a crucial component within the broader healthcare sector. Founded in 1980, the company has evolved into a vital provider of outpatient imaging services across the United States, leveraging both organic growth and strategic acquisitions. RadNet operates a network of imaging centers, equipped with cutting-edge technology and staffed by experienced radiologists and technicians. These centers offer a range of diagnostic imaging procedures, including MRI, CT, mammography, X-ray, and ultrasound. By positioning itself at the intersection of healthcare efficiency and innovation, RadNet marries technology with patient care, optimizing the process of disease detection and diagnosis. Revenue streams for RadNet primarily flow from patient payments and insurance reimbursements for services rendered. With the increasing reliance on advanced imaging techniques in modern medicine, RadNet capitalizes on the demand for accurate, timely diagnostic data from healthcare providers aiming to enhance patient care protocols. Another key revenue avenue stems from partnerships with hospitals and healthcare systems, wherein RadNet provides the technical platform and expertise, thus enabling these institutions to focus on core patient care activities. This business model not only underscores the importance of diagnostic services in preventive and restorative healthcare but also sharpens RadNet’s competitive edge through scale, efficiency, and an extensive network of service locations.

RDNT Intrinsic Value
44.46 USD
Overvaluation 27%
Intrinsic Value
Price $61.28

See Also

What is RadNet Inc's Total Equity?
Total Equity
1.1B USD

Based on the financial report for Dec 31, 2025, RadNet Inc's Total Equity amounts to 1.1B USD.

What is RadNet Inc's Total Equity growth rate?
Total Equity CAGR 10Y
42%

Over the last year, the Total Equity growth was 21%. The average annual Total Equity growth rates for RadNet Inc have been 48% over the past three years , 46% over the past five years , and 42% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett